Cybin (HELP) Amortizatization of Intangibles (2020 - 2023)
Cybin (HELP) posted quarterly Amortizatization of Intangibles of -$61376.7 for Q1 2023, down 121.52% year-on-year from $285273.4 in Q1 2022, and down 420.43% on a QoQ basis from $19154.3 in Q4 2022.
Cybin (HELP) Amortizatization of Intangibles (2020 - 2023) Analysis & Trends
Cybin (HELP) has reported Amortizatization of Intangibles for 4 consecutive years, with -$61376.7 the latest figure, recorded in Q1 2023.
- Quarterly Amortizatization of Intangibles fell 121.52% year-over-year to -$61376.7 in Q1 2023, while the trailing twelve-month figure through Feb 2023 was -$42248.5 (down 111.72% YoY) and the FY2023 annual result came in at -$284065.6, down 195.46% from the prior year.
- Amortizatization of Intangibles eased to -$61376.7 in Q1 2023 per HELP's latest filing, from $19154.3 in the prior quarter.
- Over the last five years, Amortizatization of Intangibles for HELP reached as high as $285273.4 in Q1 2022 and fell as low as -$61376.7 in Q1 2023.
- A 4-year average of $36118.4 and a median of -$26.0 in 2022 frame the typical range for Amortizatization of Intangibles.
- Annual changes were most pronounced in 2022 — Amortizatization of Intangibles soared 32564.88% — and 2023, when it slumped 121.52%.
- Year by year, Amortizatization of Intangibles stood at $7212.0 in 2020, then sank by 100.82% to -$59.0 in 2021, then surged by 32564.88% to $19154.3 in 2022, then sank by 420.43% to -$61376.7 in 2023.
- According to Business Quant data, Amortizatization of Intangibles over the past three periods registered -$61376.7, $19154.3, and -$26.0 for Q1 2023, Q4 2022, and Q1 2022 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 3.22 Mn |
| 10 | Cybin | 269.55 Mn | 269.55 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2023 | -61,376.75 |
| Feb 28, 2023 | -61,376.75 |
| Dec 31, 2022 | 19,154.28 |
| Dec 31, 2022 | 19,154.28 |
| Mar 31, 2022 | -26.00 |
| Mar 31, 2022 | -26.00 |
| Feb 28, 2022 | 285,273.43 |
| Feb 28, 2022 | 285,273.43 |
| Dec 31, 2021 | -59.00 |
| Dec 31, 2021 | -59.00 |
| Sep 30, 2021 | -55,608.65 |
| Sep 30, 2021 | -55,608.65 |
| Jun 30, 2021 | 130,977.87 |
| Jun 30, 2021 | 130,977.87 |
| Mar 31, 2021 | -482.00 |
| Mar 31, 2021 | -482.00 |
| Jun 30, 2020 | 7,212.04 |
| Jun 30, 2020 | 7,212.04 |